Advice
Following a full submission:
Ciclesonide (Alvesco®) is accepted for restricted use within NHS Scotland for the prophylactic treatment of persistent asthma in adults (18 years and older).
Ciclesonide is restricted to asthma patients who require once a day administration and whose treatment is at step 2 or step 3 of the British Guideline on the Management of Asthma.
Alternative inhaled steroids are available at lower costs
Download detailed advice50KB (PDF)
Medicine details
- Medicine name:
- Ciclesonide (Alvesco®)
- SMC ID:
- 184/05
- Indication:
- Prophylactic treatment of persistent asthma in adults (18 years and older)
- Pharmaceutical company
- Altana Pharma Ltd
- BNF chapter
- Respiratory system
- Submission type
- Full
- Status
- Restricted
- Date advice published
- 11 July 2005